Lunch for Hungry Minds with Dr. Stephen Popielarski
Thermaquil: Developing the Ideal Implantable Nerve Block Device
Join us for lunch with Dr. Stephen Popielarski, CEO of Thermaquil, Inc.
More than 100 million people in the US suffer from disorders caused by overactive neural activity such as chronic pain, severe obesity and some forms of heart failure. Dr. Popielarski will introduce Thermaquil's discovery that nerve conduction can be controllably blocked without drugs or electric stimulation by gently warming and cooling any nerve. Review feline study results, learn about potential applications of this platform technology and discuss ongoing development activities in this presentation.